Insider · CIK 0001970009

Patience David

Reports to the SEC for 2 companies · WESTMINSTER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001970009

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-01	TLSITriSalus Life Sciences, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−14.7K sh	$4.46	−$65.3K	261,107
2026-05-15	TLSITriSalus Life Sciences, Inc.P Purchase	Chief Financial Officer	PPurchase	+7,100 sh	$2.43	+$17.3K	275,757
2026-02-23	TLSITriSalus Life Sciences, Inc.P Purchase	Chief Financial Officer	PPurchase	+3,657 sh	$4.10	+$15K	268,657
2025-11-24	TLSITriSalus Life Sciences, Inc.A Award	Chief Financial Officer	AAward	+65K sh	—	—	265,000
2025-11-24	TLSITriSalus Life Sciences, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+130K sh	—	—	668,899
2025-08-28	TLSITriSalus Life Sciences, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+249K sh	—	—	538,899
2025-08-14	TLSITriSalus Life Sciences, Inc.A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2025-08-14	TLSITriSalus Life Sciences, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+290K sh	—	—	290,000
2025-04-01	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+20K sh	—	—	71,384
2025-04-01	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−6,816 sh	$0.71	−$4,839.36	64,568
2025-04-01	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−20K sh	—	—	30,000
2025-02-26	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,500 sh	—	—	51,919
2025-02-26	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−535 sh	$1.09	−$583.15	51,384
2025-02-26	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,500 sh	—	—	0
2024-05-29	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+120K sh	—	—	120,000
2024-04-09	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+37.5K sh	—	—	63,715
2024-04-09	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−13.3K sh	$0.87	−$11.6K	50,419
2024-04-09	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−37.5K sh	—	—	0
2024-03-05	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+37.5K sh	—	—	37,468
2024-02-26	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,000 sh	—	—	26,597
2024-02-26	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−350 sh	$0.96	−$336	26,247
2024-02-26	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,000 sh	—	—	1,500
2024-01-23	Accelerate Diagnostics, IncA Award	Chief Financial Officer	AAward	+16.7K sh	—	—	25,597
2024-01-23	Accelerate Diagnostics, IncCommon Stock Warrants (right to buy)A Award	Chief Financial Officer	AAward	+16.7K sh	—	—	16,666
2023-12-13	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+331 sh	—	—	9,028
2023-12-13	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−97 sh	$4.39	−$425.83	8,931
2023-12-13	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−331 sh	—	—	0
2023-11-13	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+331 sh	—	—	8,794
2023-11-13	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−97 sh	$5.57	−$540.29	8,697
2023-11-13	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−331 sh	—	—	331
2023-10-13	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+331 sh	—	—	8,559
2023-10-13	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−96 sh	$5.83	−$559.68	8,463
2023-10-13	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−331 sh	—	—	662
2023-09-13	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+331 sh	—	—	8,324
2023-09-13	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−96 sh	$6.53	−$626.88	8,228
2023-09-13	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−331 sh	—	—	993
2023-08-14	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−95 sh	$6.80	−$646	7,993
2023-08-13	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+331 sh	—	—	8,088
2023-08-13	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−331 sh	—	—	1,324
2023-07-13	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+330 sh	—	—	7,849
2023-07-13	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−92 sh	$6.90	−$634.8	7,757
2023-07-13	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−330 sh	—	—	1,655
2023-06-18	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+612K sh	—	—	611,842
2023-06-13	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,309 sh	—	—	76,479
2023-06-13	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−1,287 sh	$0.90	−$1,158.3	75,192
2023-06-13	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,309 sh	—	—	19,853
2023-05-15	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,309 sh	—	—	74,392
2023-05-15	Accelerate Diagnostics, IncS Sale	Chief Financial Officer	SSale	−1,222 sh	$0.69	−$843.18	73,170
2023-05-15	Accelerate Diagnostics, IncEmployee Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,309 sh	—	—	23,162
2023-04-13	Accelerate Diagnostics, IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,309 sh	—	—	72,230

Recent filings

Accepted (ET)
Jul 64
Patience David0001628280-26-047217
SEC(opens sec.gov)
May 184
Patience David0001628280-26-035992
SEC(opens sec.gov)
Feb 234
Patience David0001628280-26-010606
SEC(opens sec.gov)
Nov 254
Patience David0001970009-25-000004
SEC(opens sec.gov)
Aug 294
Patience David0001826667-25-000131
SEC(opens sec.gov)
Aug 154
Patience David0001826667-25-000121
SEC(opens sec.gov)
Apr 24
Patience David0001104659-25-031298
SEC(opens sec.gov)
Feb 274
Patience David0001104659-25-018521
SEC(opens sec.gov)
May 304
Patience David0001104659-24-066658
SEC(opens sec.gov)
Apr 104
Patience David0001104659-24-045899
SEC(opens sec.gov)
Mar 64
Patience David0001104659-24-031600
SEC(opens sec.gov)
Feb 274
Patience David0001104659-24-028325
SEC(opens sec.gov)

Companies

Address

6272 W. 91ST AVENUE

WESTMINSTER, CO, 80031